matiskiba Ravpage Plugin up to 2.33 on WordPress cross site scripting
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 4.2 | $0-$5k | 0.00 |
Summary
A vulnerability classified as problematic has been found in matiskiba Ravpage Plugin up to 2.33 on WordPress. Affected by this issue is some unknown functionality. Performing a manipulation results in cross site scripting. This vulnerability was named CVE-2025-68835. The attack may be initiated remotely. There is no available exploit.
Details
A vulnerability, which was classified as problematic, was found in matiskiba Ravpage Plugin up to 2.33 on WordPress. This affects some unknown processing. The manipulation with an unknown input leads to a cross site scripting vulnerability. CWE is classifying the issue as CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. This is going to have an impact on integrity. The summary by CVE is:
Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in matiskiba Ravpage ravpage allows Reflected XSS.This issue affects Ravpage: from n/a through <= 2.33.
The weakness was presented by Skalucy. The advisory is shared at patchstack.com. This vulnerability is uniquely identified as CVE-2025-68835 since 12/24/2025. The exploitability is told to be easy. It is possible to initiate the attack remotely. No form of authentication is needed for exploitation. It demands that the victim is doing some kind of user interaction. Neither technical details nor an exploit are publicly available. MITRE ATT&CK project uses the attack technique T1059.007 for this issue.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
The vulnerability is also documented in the vulnerability database at EUVD (EUVD-2026-4015). If you want to get the best quality for vulnerability data then you always have to consider VulDB.
Product
Type
Vendor
Name
Version
- 2.0
- 2.1
- 2.2
- 2.3
- 2.4
- 2.5
- 2.6
- 2.7
- 2.8
- 2.9
- 2.10
- 2.11
- 2.12
- 2.13
- 2.14
- 2.15
- 2.16
- 2.17
- 2.18
- 2.19
- 2.20
- 2.21
- 2.22
- 2.23
- 2.24
- 2.25
- 2.26
- 2.27
- 2.28
- 2.29
- 2.30
- 2.31
- 2.32
- 2.33
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 4.3VulDB Meta Temp Score: 4.2
VulDB Base Score: 4.3
VulDB Temp Score: 4.2
VulDB Vector: 🔒
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔒
ATT&CK: 🔒
Physical: No
Local: No
Remote: Yes
Availability: 🔒
Status: Not defined
EPSS Score: 🔒
EPSS Percentile: 🔒
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔒
Timeline
12/24/2025 CVE reserved01/22/2026 Advisory disclosed
01/22/2026 VulDB entry created
01/28/2026 VulDB entry last update
Sources
Advisory: patchstack.comResearcher: Skalucy
Status: Not defined
CVE: CVE-2025-68835 (🔒)
GCVE (CVE): GCVE-0-2025-68835
GCVE (VulDB): GCVE-100-342453
EUVD: 🔒
Entry
Created: 01/22/2026 20:02Updated: 01/28/2026 17:12
Changes: 01/22/2026 20:02 (55), 01/28/2026 17:12 (1)
Complete: 🔍
Cache ID: 216::103
If you want to get the best quality for vulnerability data then you always have to consider VulDB.
No comments yet. Languages: en.
Please log in to comment.